Johnson & Johnson (JNJ)
154.28
+1.61
(+1.05%)
USD |
NYSE |
May 16, 16:00
154.34
+0.06
(+0.04%)
Pre-Market: 04:28
Johnson & Johnson Market Cap: 371.30B for May 16, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 371.30B |
| May 15, 2024 | 367.43B |
| May 14, 2024 | 364.32B |
| May 13, 2024 | 363.94B |
| May 10, 2024 | 360.79B |
| May 09, 2024 | 360.64B |
| May 08, 2024 | 358.47B |
| May 07, 2024 | 357.92B |
| May 06, 2024 | 357.58B |
| May 03, 2024 | 359.25B |
| May 02, 2024 | 360.81B |
| May 01, 2024 | 363.84B |
| April 30, 2024 | 347.98B |
| April 29, 2024 | 353.35B |
| April 26, 2024 | 351.71B |
| April 25, 2024 | 353.35B |
| April 24, 2024 | 357.47B |
| April 23, 2024 | 359.95B |
| April 22, 2024 | 358.89B |
| April 19, 2024 | 355.98B |
| April 18, 2024 | 350.76B |
| April 17, 2024 | 348.42B |
| April 16, 2024 | 347.65B |
| April 15, 2024 | 355.21B |
| April 12, 2024 | 355.04B |
| Date | Value |
|---|---|
| April 11, 2024 | 358.10B |
| April 10, 2024 | 361.49B |
| April 09, 2024 | 366.52B |
| April 08, 2024 | 364.84B |
| April 05, 2024 | 366.76B |
| April 04, 2024 | 367.03B |
| April 03, 2024 | 371.26B |
| April 02, 2024 | 379.61B |
| April 01, 2024 | 379.73B |
| March 28, 2024 | 381.20B |
| March 27, 2024 | 380.65B |
| March 26, 2024 | 375.37B |
| March 25, 2024 | 374.05B |
| March 22, 2024 | 374.07B |
| March 21, 2024 | 375.32B |
| March 20, 2024 | 375.35B |
| March 19, 2024 | 376.43B |
| March 18, 2024 | 377.76B |
| March 15, 2024 | 381.18B |
| March 14, 2024 | 383.66B |
| March 13, 2024 | 388.22B |
| March 12, 2024 | 392.17B |
| March 11, 2024 | 388.53B |
| March 08, 2024 | 384.41B |
| March 07, 2024 | 382.84B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
293.00B
Minimum
Mar 23 2020
489.47B
Maximum
Apr 25 2022
408.27B
Average
408.27B
Median
Apr 24 2020
Market Cap Benchmarks
| Amgen Inc | 168.83B |
| Eli Lilly and Co | 732.88B |
| Merck & Co Inc | 331.49B |
| Pfizer Inc | 163.88B |
| Shockwave Medical Inc | 12.42B |
Market Cap Related Metrics
| PE Ratio | 10.16 |
| PS Ratio | 4.318 |
| PEG Ratio | 0.0467 |
| Price to Book Value | 5.303 |
| Price to Free Cash Flow | 21.23 |
| Price | 154.28 |
| Earnings Yield | 9.84% |
| PEGY Ratio | 0.0461 |
| Operating PE Ratio | 15.93 |
| Normalized PE Ratio | 18.51 |